SCHEMBL15328356

SCHEMBL15328356

Cc1cc(N2CCOCC2)cc(C2CC2)c1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
POLB P06746 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
KMO O15229 1/20 0.43
MAPT P10636 6/20 0.42
GAA P10253 1/20 0.42
LMNA P02545 1/20 0.42
MAPK1 P28482 2/20 0.39
USP2 O75604 1/20 0.39
TP53 P04637 1/20 0.39
ALOX15 P16050 1/20 0.39
HTT P42858 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PRKDC P78527 1/20 0.38
CFTR P13569 2/20 0.38
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15328086 0.84 DGAT1 (0.46) ALDH1A1KDM4EMEN1KMT2AL3MBTL1
SCHEMBL22996827 0.79 ALDH1A1 (0.50) ALDH1A1KDM4EMEN1KMT2AL3MBTL1
SCHEMBL15328484 0.76 GAA (0.48) ALDH1A1KMT2AGAALMNATP53
SCHEMBL15328400 0.76 KMT2A (0.47) ALDH1A1MEN1KMT2ALMNATP53
SCHEMBL15328509 0.75 CCR5 (0.38) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL15328600 0.75 CCR5 (0.38) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL15328398 0.75 PRMT5 (0.36) MAPTGAALMNA
SCHEMBL2770127 0.75 MAPT (0.49) ALDH1A1KDM4EMEN1KMT2AL3MBTL1
SCHEMBL15328121 0.74 BRAF (0.45) KMT2AMAPTGAALMNATP53
SCHEMBL2130499 0.74 GBA1 (0.48) ALDH1A1KDM4EMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9108936-B2 Substituted 4-aminobenzamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2015-08-18 US disclosed
EP-2844645-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2015-03-11 EP disclosed
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS GRUENENTHAL GMBH (DE) 2013-10-24 US disclosed
WO-2013156155-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2013-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS KCNJ2, KCNQ2, KCNQ1 ALDH1A1 3041/4885KDM4E 245/4885MEN1 4108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.